One-third of antimalarial medicines tested in six African countries fail to meet international quality standards
M
Points to consider for inspections of biowaiver data
M
The WHO Prequalification of Medicines Programme (PQP) intends to include in its inspection programme, sites that have performed comparative dissolution studies submitted in prod
Notice of concern (NOC) withdrawn for Bombay Bioresearch Center (BBRC), India
M
Following corrective actions taken by Bombay Bioresearch Center (BBRC) and the clarifications provided being considered acceptable, and considering the outcome of an additional inspe
Relenza Rotacap/Rotahaler removed from WHO List of Prequalified Medicinal Products
M
The Swedish Medical Product Ag
Revised WHO good practices for pharmaceutical quality control laboratories
M
The WHO Prequalification of Medicines Programme has posted on its website revised WHO Good Practices for Pharmaceutical Quality Control Laboratories, Annex 1 (WHO T
Notice of concern (NOC) withdrawn for Sandoz SA (Pty) Ltd, Kempton Park, South Africa
M
Following re-inspection of Sandoz SA (pty) Ltd, Kempton Park site in South Africa, the WHO Prequalification of Medicines Programme has
Requalification to start
M
In accordance with the provisions set out in sec